The Murky Post-Pandemic Future of Hepatitis C Elimination in the U.S.
About 25% fewer patients with hepatitis C virus (HCV) were initiated on treatment in 2020 compared with 2019 due to the COVID-19 pandemic, though the WHO target for elimination may not be entirely out of reach, a researcher said. If HCV programs are able to rebound from the pandemic and return to their original forecast, […]
FDA Authorizes IL-6 Inhibitor for Severe COVID-19 Patients
Tocilizumab (Actemra), an interleukin-6 (IL-6) inhibitor, was authorized to treat certain hospitalized COVID-19 patients, the FDA announced late on Thursday. The drug received emergency use authorization (EUA) for hospitalized patients ages 2 and up who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ECMO). It is […]